Literature DB >> 22879843

Particular clinical and therapeutical aspects in acute myeloid leukemia in elderly patients.

Andrei Colita1, Anca Colita, Nicoleta Mariana Berbec, Silvana Angelescu, Anca Roxana Lupu.   

Abstract

Entities:  

Year:  2011        PMID: 22879843      PMCID: PMC3391946     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


× No keyword cloud information.
  16 in total

1.  Treatment of acute myeloid leukemia in the elderly.

Authors:  Elihu H Estey
Journal:  Haematologica       Date:  2011-06       Impact factor: 9.941

2.  European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.

Authors:  Alan K Burnett; Nigel H Russell; Jonathan Kell; Michael Dennis; Donald Milligan; Stefania Paolini; John Yin; Dominic Culligan; Peter Johnston; John Murphy; Mary-Frances McMullin; Ann Hunter; Emma Das-Gupta; Richard Clark; Robert Carr; Robert K Hills
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

3.  Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial.

Authors:  A H Goldstone; A K Burnett; K Wheatley; A G Smith; R M Hutchinson; R E Clark
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

4.  AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance.

Authors:  Hendrik J M de Jonge; Eveline S J M de Bont; Peter J M Valk; Jan Jacob Schuringa; Marcel Kies; Carolien M Woolthuis; Ruud Delwel; Nic J G M Veeger; Edo Vellenga; Bob Löwenberg; Gerwin Huls
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

5.  Age and acute myeloid leukemia.

Authors:  Frederick R Appelbaum; Holly Gundacker; David R Head; Marilyn L Slovak; Cheryl L Willman; John E Godwin; Jeanne E Anderson; Stephen H Petersdorf
Journal:  Blood       Date:  2006-02-02       Impact factor: 22.113

6.  High-dose daunorubicin in older patients with acute myeloid leukemia.

Authors:  Bob Löwenberg; Gert J Ossenkoppele; Wim van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Johan Maertens; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Marinus van Marwijk Kooy; Leo F Verdonck; Joachim Beck; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gregor Verhoef
Journal:  N Engl J Med       Date:  2009-09-24       Impact factor: 91.245

Review 7.  Acute myelogenous leukemia in older adults.

Authors:  Heidi D Klepin; Lodovico Balducci
Journal:  Oncologist       Date:  2009-03-12

8.  Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.

Authors:  Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria-Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

9.  Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.

Authors:  Arati V Rao; Peter J M Valk; Klaus H Metzeler; Chaitanya R Acharya; Sascha A Tuchman; Marvaretta M Stevenson; David A Rizzieri; Ruud Delwel; Christian Buske; Stefan K Bohlander; Anil Potti; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2009-10-26       Impact factor: 44.544

Review 10.  Current and emerging strategies for the management of acute myeloid leukemia in the elderly.

Authors:  Jacob Laubach; Arati V Rao
Journal:  Oncologist       Date:  2008-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.